Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston. 2007

Kathryn A Mason, and Michael T Gillin, and Radhe Mohan, and James D Cox
Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

The clinical use of protons for the treatment of cancer is one of the most technologically advanced forms of therapy. The newly commissioned M.D. Anderson Cancer Center, Proton Therapy Center Houston is one of the newest facilities offering a complete range of advanced proton therapies designed specifically to minimize treatment-related normal tissue toxicity. As an integral part of the clinical commissioning of this proton beam, we performed an in vivo assessment of the relative biologic effectiveness of the 250-MeV protons relative to standard cobalt(60) using the jejunal crypt microcolony assay in mice. Our data are consistent with a generic relative biologic effectiveness of 1.1, and this relative biologic effectiveness is in agreement with that used to describe most other clinical proton therapy beams worldwide.

UI MeSH Term Description Entries
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D012062 Relative Biological Effectiveness The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays. Biological Effectiveness, Relative,Effectiveness, Biologic Relative,Effectiveness, Biological Relative,Relative Biologic Effectiveness,Biologic Effectiveness, Relative,Biologic Relative Effectiveness,Biological Relative Effectiveness,Effectiveness, Relative Biologic,Effectiveness, Relative Biological,Relative Effectiveness, Biologic
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D005260 Female Females
D006782 Hospitals, Special Hospitals which provide care for a single category of illness with facilities and staff directed toward a specific service. Special Hospital,Hospital, Special,Special Hospitals
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013781 Texas State bounded on the north by Oklahoma, on the east by Arkansas and Louisiana, on the south by Mexico, and on the west by New Mexico.

Related Publications

Kathryn A Mason, and Michael T Gillin, and Radhe Mohan, and James D Cox
June 2002, International journal of radiation oncology, biology, physics,
Kathryn A Mason, and Michael T Gillin, and Radhe Mohan, and James D Cox
November 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Kathryn A Mason, and Michael T Gillin, and Radhe Mohan, and James D Cox
November 2002, International journal of radiation oncology, biology, physics,
Kathryn A Mason, and Michael T Gillin, and Radhe Mohan, and James D Cox
January 1998, Radiation medicine,
Kathryn A Mason, and Michael T Gillin, and Radhe Mohan, and James D Cox
April 2012, Radiation protection dosimetry,
Kathryn A Mason, and Michael T Gillin, and Radhe Mohan, and James D Cox
January 2023, In vivo (Athens, Greece),
Kathryn A Mason, and Michael T Gillin, and Radhe Mohan, and James D Cox
July 2005, International journal of radiation oncology, biology, physics,
Kathryn A Mason, and Michael T Gillin, and Radhe Mohan, and James D Cox
September 2014, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!